Evidence map›Paper›PMID 38255413›Full record

ArticleChildren (Basel, Switzerland)2024

Evaluating Adherence to Therapeutic Drug Monitoring Guidelines for Gentamicin in Neonatal Care: A Retrospective Study at the Maternity and Children's Hospital in Makkah.

Abdullah Najeh Bajaber, Mahmoud Elrggal, Wajdi F Organji, Mohammad Adil Sulaimani, Raed Mohammed Refai, Ashraf Alsaedi, Salwa Hashim Alzamzami, Fatimah Bakor Hawsawi, Saud Tanadhub Alnefaie, Azhar Ali Alsulaimani and 5 more

Open access · goldAbstract read
In one paragraph

Article in Children (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Abdullah Najeh BajaberMaternity and Children Hospital, Ministry of Health, Makkah 24246, Saudi Arabia.
Mahmoud ElrggalPharmacology & Toxicology Department, Faculty of Medicine, Al Qunfudah, Umm Al-Qura University, Makkah 21961, Saudi Arabia.ORCID 0000-0002-0026-5514
Wajdi F OrganjiMaternity and Children Hospital, Ministry of Health, Makkah 24246, Saudi Arabia.ORCID 0000-0001-9286-599X
Mohammad Adil SulaimaniMaternity and Children Hospital, Ministry of Health, Makkah 24246, Saudi Arabia.ORCID 0009-0006-0035-1080
Raed Mohammed RefaiMaternity and Children Hospital, Ministry of Health, Makkah 24246, Saudi Arabia.
Ashraf AlsaediMaternity and Children Hospital, Ministry of Health, Makkah 24246, Saudi Arabia.ORCID 0009-0001-7429-1002
Salwa Hashim AlzamzamiMaternity and Children Hospital, Ministry of Health, Makkah 24246, Saudi Arabia.ORCID 0000-0001-8376-402X
Fatimah Bakor HawsawiMaternity and Children Hospital, Ministry of Health, Makkah 24246, Saudi Arabia.
Saud Tanadhub AlnefaieMaternity and Children Hospital, Ministry of Health, Makkah 24246, Saudi Arabia.
Azhar Ali AlsulaimaniMaternity and Children Hospital, Ministry of Health, Makkah 24246, Saudi Arabia.
Adnan AlharbiPharmaceutical Practices Department, College of Pharmacy, Umm Al-Qura University, Makkah 24382, Saudi Arabia.ORCID 0000-0002-4825-6596
Mohammed AlnuhaitPharmaceutical Practices Department, College of Pharmacy, Umm Al-Qura University, Makkah 24382, Saudi Arabia.ORCID 0000-0002-5279-5437
Abdullah S AlshammariPharmaceutical Practices Department, College of Pharmacy, Umm Al-Qura University, Makkah 24382, Saudi Arabia.ORCID 0000-0002-9994-7266
Abdu AldarhamiDepartment of Medical Microbiology, Faculty of Medicine, Al Qunfudah, Umm Al-Qura University, Makkah 21961, Saudi Arabia.ORCID 0000-0002-0950-9263
Sharaf E SharafPharmaceutical Sciences Department, College of Pharmacy, Umm Al-Qura University, Makkah 24382, Saudi Arabia.ORCID 0000-0002-0679-6586
Maternity and Children's Hospital · SAUmm al-Qura University · SA

Funding

Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia IFP22UQU4320605DSR240
6 · The paper itself

Abstract

In this study, we assess healthcare providers' adherence to therapeutic drug monitoring (TDM) guidelines for gentamicin in neonates. Conducted at the Maternity and Children's Hospital in Makkah, Saudi Arabia, from July 2020 to July 2022, it retrospectively analyzed the compliance of healthcare workers in managing neonates treated with gentamicin. Covering 410 neonates, primarily diagnosed with respiratory distress (56%) and sepsis (32%), the study revealed that while a majority of trough and peak levels conformed to guidelines, substantial deviations were noted in cases of respiratory distress. This underlines the necessity for targeted TDM strategies, particularly in managing respiratory distress in neonates, to ensure optimal treatment efficacy and safety. The findings urge stringent compliance with TDM guidelines, emphasizing personalized approaches in neonatal gentamicin therapy for improved healthcare outcomes.

Indexed as

gentamicinneonatal carerespiratory distresstherapeutic drug monitoring (TDM)

Identifiers

PMID38255413
PMCPMC10814964
OpenAlexW4390880612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.